Converge Bio
PrivateLast Round
Grant
Jun 2, 2026
Est. Valuation
$90M
Total Funding Raised
$33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Converge Bio is a biotechnology company that provides a generative AI platform using large language models trained on biological and chemical data to accelerate drug discovery and development for pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Converge Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Converge Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Early Stage VC | Apr 28, 2026 | ||||
| Series A | Jan 13, 2026 | ||||
| Seed | Nov 20, 2024 |
Key People
Founding team and executive leadership
Converge Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Series A |
| Vintage Investment Partners | Series A |
| TLV Partners | Series A, Seed |
| Bill & Melinda Gates Foundation | Grant |
| Bessemer Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$25M raised in early stage VC round.
- Jan 13, 2026
$25M round completed.
Converge Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Converge Bio's valuation, stock price, and market status.